Drugs
Ajinomoto Co., Inc. and Sankyo Co., Ltd., both based in Tokyo, Japan, have entered into an agreement granting Sankyo exclusive global rights to develop, manufacture, and market the new diabetes drug AJD101 and related compounds. The collaboration marks the second partnership between the two companies, following their successful collaboration on
Drugs
Recent research from Canada, Denmark, and Malaysia has shed light on the complexities of diabetes, a chronic condition affecting millions worldwide. The findings from these studies provide valuable insights into the molecular mechanisms underlying diabetes and propose novel therapeutic approaches. Key Takeaways: * Study 1 from Canada found that alpha-lipoic acid
Drugs
Recent studies from the United States, Taiwan, and Australia have shed light on the crucial role of adiponectin in diabetes prevention and management. Researchers have discovered that adiponectin suppresses reactive oxygen species (ROS) production in vascular endothelial cells, improves insulin sensitivity, and has anti-inflammatory properties. These findings have significant implications
Drugs
Research from scientists in Australia, Japan, and the United States has shed new light on retinopathy, a leading cause of vision loss worldwide. Recent studies have focused on understanding the underlying mechanisms of angiogenesis, the formation of new blood vessels, which is a hallmark of retinopathy. Three studies have made
Drugs
Research from Turkey, Italy, and the United States has shed light on the impact of statins on diabetic patients, particularly in relation to coronary collateral development. A study in the American Journal of Cardiology found that statin treatment and stable angina pectoris are associated with better coronary collateral development in
Drugs
Pregnant women with Type 1 diabetes and microalbuminuria face a higher risk of preterm delivery. Researchers have investigated the impact of early antihypertensive treatment with methyldopa on this risk. In a study published in Diabetic Medicine, investigators found that introducing early antihypertensive treatment with methyldopa resulted in a significant reduction
Drugs
Recent research has identified a novel therapeutic approach for heritable breast cancer, leveraging the transcriptional activation of PPAR gamma by Lovastatin and Rosiglitazone. According to a study published in the International Journal of Cancer, the activation of PPAR gamma by these compounds induces PTEN expression, a tumor suppressor gene that
Diabetes mellitus
The Juvenile Diabetes Research Foundation has partnered with Applied Genetic Technologies Corp. (AGTC) and Genzyme Corp. to develop a gene therapy treatment to prevent blindness caused by diabetic retinopathy. As part of the partnership, JDRF will provide up to $1 million in milestone-driven payments over two years, contingent on the
Diabetes mellitus
Researchers in Canada, the United States, and Germany have made significant breakthroughs in understanding diabetes, particularly type 2 diabetes. Recent studies have focused on the action of incretin hormones, such as glucagon-like peptide-1 (GLP-1), and their potential as therapeutic agents. The findings of these studies have the potential to revolutionize
Diabetes mellitus
A recent wave of research has provided valuable insights into the intricacies of diabetes, with studies from France, the United States, and Italy shedding light on the mechanisms of insulin secretion, sensitivity, and glycemic control. The findings of these studies have significant implications for the treatment and management of type
Diabetes mellitus
A trio of studies from Japan and France sheds light on the complex relationships between diabetes, cholesterol levels, and glomerular filtration rates. Researchers have identified compelling evidence of glomerular hyperfiltration in nonproteinuric and nonhypertensive Japanese type 2 diabetic patients, while also investigating the effects of atorvastatin on low-density lipoprotein cholesterol
Diabetes mellitus
A recent spate of studies from the United Kingdom and Japan has shed new light on various aspects of diabetes management and the underlying factors influencing glucose regulation. Researchers in both countries have made significant discoveries, ranging from the impact of injection timing for exenatide to the effect of thorough
